Recalibration of Framingham risk for a local population of Sri Lanka

Sameera Upashantha Ranasinghe1, E M D S Ekanayake2, Laksitha Iroshan Ranasinghe3

  • 1Ministry of Health, Nutrition and Indigenous Medicine, Colombo, Sri Lanka. rasu.ranasinghe@gmail.com.

BMC Public Health
|January 12, 2024
PubMed

Insights

Recalibrating the Framingham cardiovascular disease (CVD) risk equation for Sri Lanka

Area of Science:

  • Cardiovascular disease epidemiology
  • Public health research
  • Health risk assessment

Background:

  • Cardiovascular Diseases (CVD) are a leading cause of death and disability globally and in Sri Lanka.
  • Accurate CVD risk prediction is crucial for cost-effective prevention, especially in resource-limited settings.
  • Existing risk models may not accurately reflect local risk factor distributions within Sri Lanka.

Purpose of the Study:

  • To recalibrate the Framingham cardiovascular disease (CVD) risk equation.
  • To adapt the CVD risk assessment tool to the local risk factor profile of the Kurunegala region in Sri Lanka.

Main Methods:

  • A cross-sectional study involving 1,102 participants from the Kurunegala region.
  • Data collection via interviewer-administered questionnaires, anthropometric, blood pressure, and biochemical measurements.
  • Estimation of CVD risk using original and recalibrated Framingham equations, incorporating local mortality and morbidity data.

Main Results:

  • The original Framingham equation over-predicted CVD risk in the study population.
  • Recalibration adjusted risk predictions, with significant shifts in the proportion of individuals categorized with low (<10%) and high (>40%) CVD risk.
  • Original scores predicted 55.5% with <10% risk vs. 62.3% with recalibrated scores; 2.2% with >40% risk vs. 1.8% with recalibrated scores.

Conclusions:

  • The findings highlight the necessity of developing region-specific CVD risk prediction tools for Sri Lanka.
  • Using a locally recalibrated tool can prevent over-treatment and unnecessary healthcare expenditure.
  • Implementing localized risk assessment improves the efficiency of CVD prevention strategies.
Abstract